echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > The country's five new crown vaccines entered Phase III. Clinically, four of which were developed in Beijing

    The country's five new crown vaccines entered Phase III. Clinically, four of which were developed in Beijing

    • Last Update: 2021-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medicine Network December 25th, in the afternoon of December 24th, Beijing "review the '13th Five-Year' Outlook '14th Five-Year' series of thematic press conference on scientific and technological innovation, Beijing Municipal Science and Technology Commission deputy director, press spokesman Yang Renquan introduced, so far, the country has 5 The new crown vaccine entered Phase III. Clinical, of which Beijing research and development accounted for 4, the country has 5 teams of medium antibody drugs approved clinical, research and development are from Beijing, the city's 9 diagnostic reagent products were approved for market, the number of the first in the country.
    Yang Renquan, "13th Five-Year", the city adheres to the people's life and health, strengthen science and technology to support the prevention and control of the epidemic, the people to obtain a sense of well-being and security significantly enhanced. during the
    epidemic, Beijing established a war-time mechanism, issued "10" to strengthen the new crown pneumonia science and technology, organized the dominant forces to carry out vaccines, diagnostic reagents, drug research and development, strengthen big data, artificial intelligence and new materials and other technical applications, science and technology to fight the epidemic made important progress.
    addition to the outstanding performance of Beijing's scientific and technological innovation in vaccine research and development, the city also supported the development of AI image-assisted diagnostic products, the new crown pneumonia online doctor consultation platform and other new products.
    deep use of big data technology to accurately carry out confirmed case traceability, flow and personnel risk identification in and out of Beijing, after the outbreak of new aggregation, only less than 16 hours to accurately target the source of the spread of the outbreak and quickly identify high-risk personnel.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.